Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Research Scholarships - Master's program

University of Ottawa

$27,000.00

Fecal microbiota transplantation for treating intestinal dysbiosis in the critical care setting

EF 2025-26

Résumé
Common intensive care unit (ICU) factors like infections, hypoxemia, and hypotension can alter the gut bacterial community resulting in a pathological state termed intestinal dysbiosis. This complication leads to organ failure and death in critically ill patients. Fecal microbiota transplantation (FMT) is a novel intervention with the potential to treat intestinal dysbiosis in the ICU setting. FMT works by transplanting stool from a healthy donor to reintroduce bacterial diversity, suppress pathogenic species, and restore microbial signals that support immune balance – factors that may reduce organ failure and death in the critically ill. FMT has been successfully used for treating recurrent and refractory Clostridium difficile, a potentially life-threatening colon infection. However, no rigorous studies using this therapy have been performed on general ICU patients. My research program aims to assess whether FMT can improve outcomes in ICU patients. This program will comprise several foundational projects, including 1) a scoping review of randomized controlled trials assessing FMT in adult patients to summarize the existing evidence; 2) a series of World Café virtual meetings with patient and family partners across Canada to develop patient oriented outcomes measures; 3) multiple focus group sessions with ICU research coordinators and nurse educators nationwide to refine our study implementation plan; and 4) a quantitative survey of ICU physicians across Canada examining their knowledge and attitudes towards providing FMT. This systematic and collaborative approach will ultimately enable our team to design and conduct a large multi-centre randomized controlled trial that will assess the efficacy of FMT for improving patient important outcomes in the critically ill.
Programme
Master's Award: Canada Graduate Research Scholarships - Master's program
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
573116
Name
Durr Kevin M
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Fecal microbiota transplantation for treating intestinal dysbiosis in the critical care setting
Programtype2
Studentship Programs
Orgnameinp2
University of Ottawa
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Critical Care; Fecal Microbiota Transplantation; Intensive Care; Intestinal Dysbiosis; Mortality; Organ Dysfunction
Abstract
Common intensive care unit (ICU) factors like infections, hypoxemia, and hypotension can alter the gut bacterial community resulting in a pathological state termed intestinal dysbiosis. This complication leads to organ failure and death in critically ill patients. Fecal microbiota transplantation (FMT) is a novel intervention with the potential to treat intestinal dysbiosis in the ICU setting. FMT works by transplanting stool from a healthy donor to reintroduce bacterial diversity, suppress pathogenic species, and restore microbial signals that support immune balance – factors that may reduce organ failure and death in the critically ill. FMT has been successfully used for treating recurrent and refractory Clostridium difficile, a potentially life-threatening colon infection. However, no rigorous studies using this therapy have been performed on general ICU patients. My research program aims to assess whether FMT can improve outcomes in ICU patients. This program will comprise several foundational projects, including 1) a scoping review of randomized controlled trials assessing FMT in adult patients to summarize the existing evidence; 2) a series of World Café virtual meetings with patient and family partners across Canada to develop patient oriented outcomes measures; 3) multiple focus group sessions with ICU research coordinators and nurse educators nationwide to refine our study implementation plan; and 4) a quantitative survey of ICU physicians across Canada examining their knowledge and attitudes towards providing FMT. This systematic and collaborative approach will ultimately enable our team to design and conduct a large multi-centre randomized controlled trial that will assess the efficacy of FMT for improving patient important outcomes in the critically ill.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Durr, Kevin M
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~